In a recent study published in Nature Cardiovascular Research, researchers assessed T-cell tolerance checkpoints observed in atherosclerosis. Study: Pairing of single-cell RNA analysis and T cell ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Atherosclerosis happens when a fatty substance called plaque builds up inside your arteries. There are typically few noticeable ...
Hamilton, ON - Canadian scientists studying the causes of atherosclerosis at the cellular level have shown that nitric oxide (NO) can be converted to peroxynitrite, an agent known to accelerate ...
A study published by researchers from the Sant Pau Research Institute (IR Sant Pau) and the Stroke Unit of Sant Pau Hospital in the Journal of Lipid Research provides new evidence on the essential ...
Our risk of developing atherosclerosis -- 'furring' of the arteries -- can begin much earlier in life than was previously thought, highlighting the need to keep cholesterol levels low even when we are ...
Researchers from Queen Mary University of London have found that the molecule RvT4 enhances the body's natural defenses against atherosclerosis (hardening of the arteries) in patients with rheumatoid ...
Atherosclerosis may be stopped if lipid screening and dyslipidemia intervention begin in adolescence
Abnormal blood cholesterol and triglyceride levels known as elevated lipids and dyslipidemia are major causes of atherosclerosis where cholesterol plaques are deposited within the blood vessels. There ...
Coating nanoparticles derived from a ginger-family plant in stem cell membranes enables targeted atherosclerosis treatment.
The National Institute of Health’s National Heart, Lung and Blood Institute awarded University of North Carolina at Chapel Hill $19 million to conduct the next phase in its study focusing on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results